A fourth dose of the COVID-19 vaccine may not be as effective as expected, according to a recent peer-reviewed study. The retrospective population-based observational study published in the European Journal of Clinical Investigation used national health data from the Austrian epidemiological reporting system, individual all-cause mortality data from Statistics Austria, and the national COVID-19 vaccine […]
Research Studies
Study Shows COVID Is Less Common and Severe in Young Children Than Other Respiratory Viruses
A recent retrospective single-center study in France published Oct. 5 in Pediatric Pulmonology found infants under 2 months of age were less likely to experience SARS-CoV-2 infection and less likely to experience severe illness compared with other viral respiratory infections. Additionally, researchers found young children with COVID-19 required less respiratory support, enteral nutrition, or intensive care admission—and […]
Vitamin D Supplementation May Lower Risk of Severe COVID-19, Study Shows
A new paper found a strong association between vitamin D supplementation and a protective effect on ICU admission in COVID-19 patients, adding more scientific support to the position that alternatives exist to vaccines that may lower one’s risk of experiencing severe disease. In a study published on Jan. 23 in Pharmaceuticals, researchers conducted a meta-analysis […]
Vaccine ‘Effectiveness’ Wanes Completely Within Months of Fourth COVID Vaccine Dose
Just like the first, second and third COVID-19 vaccine doses that came before it, the “protection” of a fourth Pfizer/BioNTech (BNT162b2) vaccine dose waned completely within four months returning to similar levels seen after the third vaccine dose. According to a prospective cohort study published on Nov. 9 in The New England Journal of Medicine […]
Effectiveness of Moderna’s COVID-19 Vaccine ‘Turns Negative’ Within Months, Study Shows
The effectiveness of Moderna’s COVID-19 vaccine turns negative over time subjecting a vaccinated person to a higher risk of contracting the virus, according to a new study funded by Moderna and Kaiser Permanente. The study, published in MedRxiv ahead of peer review, evaluated the effectiveness of 3 and 4 doses of mRNA-1273 against infection with and […]